Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
10
Bearish filings
1
Named actors
9
Disclosed $ (bull / bear)
$327.2M + 4 of unknown size / size unknown
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-14 | 5%+ holder (13G) RTW INVESTMENTS, LP | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-08-05 | 5%+ holder (13G) Jiangsu Hengrui Pharmaceuticals Co., Ltd. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-06-30 | Institution (13F) SOROS FUND MANAGEMENT LLC | reported a new position | $441K | — |
| 2026-04-23 | Activist (13D) BCPE Perseus Investor, LP | disclosed an activist stake (13D) | — | SEC ↗ |
| 2026-04-23 | Activist (13D) BCLS Fund IV Investments, L.P. | disclosed an activist stake (13D) | — | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-04-20 | Director Kaplan Andrew T. | bought | $134.4M | SEC ↗ |
| 2026-04-20 | 10% owner / other Bain Capital Life Sciences Investors, LLC | bought | $25.0M | SEC ↗ |
| 2026-04-20 | Director Koppel Adam | bought | $25.0M | SEC ↗ |
| 2026-04-20 | 10% owner / other BAIN CAPITAL INVESTORS LLC | bought | $134.4M | SEC ↗ |
| 2026-04-20 | 10% owner / other RTW INVESTMENTS, LP | bought | $8.0M | SEC ↗ |
| 2026-04-17 | Issuer (share issuance) | priced an offering | — | SEC ↗ |